134 related articles for article (PubMed ID: 2364985)
1. The allosteric binding profile of himbacine: a comparison with other cardioselective muscarinic antagonists.
Lee NH; el-Fakahany EE
Eur J Pharmacol; 1990 Apr; 179(1-2):225-9. PubMed ID: 2364985
[TBL] [Abstract][Full Text] [Related]
2. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
[TBL] [Abstract][Full Text] [Related]
3. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991
[TBL] [Abstract][Full Text] [Related]
4. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
Waelbroeck M; Tastenoy M; Camus J; Christophe J
Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234
[TBL] [Abstract][Full Text] [Related]
5. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
[TBL] [Abstract][Full Text] [Related]
6. The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro.
Eglen RM; Montgomery WW; Dainty IA; Dubuque LK; Whiting RL
Br J Pharmacol; 1988 Dec; 95(4):1031-8. PubMed ID: 3219478
[TBL] [Abstract][Full Text] [Related]
7. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
Matsui H; Lazareno S; Birdsall NJ
Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
[TBL] [Abstract][Full Text] [Related]
8. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
Waelbroeck M; Robberecht P; De Neef P; Christophe J
J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
[TBL] [Abstract][Full Text] [Related]
9. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
[TBL] [Abstract][Full Text] [Related]
10. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
11. Competition between positive and negative allosteric effectors on muscarinic receptors.
Proska J; Tucek S
Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
Gillard M; Waelbroeck M; Christophe J
J Recept Res; 1986; 6(1):47-61. PubMed ID: 3754901
[TBL] [Abstract][Full Text] [Related]
13. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
Christopoulos A; Lanzafame A; Ziegler A; Mitchelson F
Biochem Pharmacol; 1997 Mar; 53(6):795-800. PubMed ID: 9113100
[TBL] [Abstract][Full Text] [Related]
14. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
Ellis J; Lenox RH
Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914
[TBL] [Abstract][Full Text] [Related]
15. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells.
Lee NH; el-Fakahany EE
J Neurochem; 1989 Oct; 53(4):1300-8. PubMed ID: 2549200
[TBL] [Abstract][Full Text] [Related]
16. On the interaction of gallamine with muscarinic receptor subtypes.
Michel AD; Delmendo RE; Lopez M; Whiting RL
Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
[TBL] [Abstract][Full Text] [Related]
17. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.
Tränkle C; Weyand O; Schröter A; Mohr K
Mol Pharmacol; 1999 Nov; 56(5):962-5. PubMed ID: 10531401
[TBL] [Abstract][Full Text] [Related]
18. Gallamine exerts biphasic allosteric effects at muscarinic receptors.
Ellis J; Seidenberg M
Mol Pharmacol; 1989 Feb; 35(2):173-6. PubMed ID: 2918854
[TBL] [Abstract][Full Text] [Related]
19. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors.
Purkerson SL; Potter LT
J Pharmacol Exp Ther; 1998 Feb; 284(2):707-13. PubMed ID: 9454818
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
Tränkle C; Kostenis E; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):172-8. PubMed ID: 11534857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
